Fluid Biomed
5 known investors
Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke. The device uses a dissolving polymer scaffold to promote blood vessel healing and simplify non-invasive follow-up imaging, and is currently limited to authorized clinical investigations.
BiotechHealthtechMedical Devices
Investors · 5
Frequently asked questions
- What does Fluid Biomed do?
- Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke. The device uses a dissolving polymer scaffold to promote blood vessel healing and simplify non-invasive follow-up imaging, and is currently limited to authorized clinical investigations.
- Who are Fluid Biomed's investors?
- Fluid Biomed's investors include Accelerate Fund, LifeArc Ventures, ShangBay Capital LLC, Thin Air Labs, UCeed Funds.